Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism

American Journal of Human Genetics

Volumn 88, Issue 4, 2011, Pages 402-421

  Erez, Ayelet ^a,b   Shchelochkov, Oleg A ^a   Plon, Sharon E ^a,b   Scaglia, Fernando ^a,b   Lee, Brendan ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CITRININ; DEOXYGUANOSINE KINASE; FUMARYLACETOACETASE; ISOCITRATE DEHYDROGENASE; PACLITAXEL; SUCCINYLACETONE;

ACUTE MYELOBLASTIC LEUKEMIA; ADENOCARCINOMA; ADRENAL CORTEX TUMOR; BILE DUCT CARCINOMA; BONE CANCER; CANCER SUSCEPTIBILITY; CANCER THERAPY; CARCINOGENESIS; CARNEY COMPLEX; COLON CANCER; CYSTADENOMA; ENZYME DEFICIENCY; FABRY DISEASE; GILBERT DISEASE; GLIOBLASTOMA; GLIOMA; HEMATOLOGIC MALIGNANCY; HEMOCHROMATOSIS; HUMAN; INBORN ERROR OF METABOLISM; KIDNEY CARCINOMA; LEIOMYOMA; LEIOMYOSARCOMA; LEYDIG CELL TUMOR; LIVER CELL CARCINOMA; NEPHROBLASTOMA; OVARY CANCER; PATHOGENESIS; PORPHYRIA; PRIORITY JOURNAL; REVIEW; TYROSINEMIA; UTERUS MYOMA; WILSON DISEASE;

CARCINOMA, HEPATOCELLULAR; DNA, MITOCHONDRIAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLISM, INBORN ERRORS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS;

EID: 79953696794     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2011.03.005     Document Type: Review

References (201)

1. F.E. Alexander, S.L. Patheal, A. Biondi, S. Brandalise, M.E. Cabrera, L.C. Chan, Z. Chen, G. Cimino, J.C. Cordoba, and L.J. Gu Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion Cancer Res. 61 2001 2542 2546 (Pubitemid 32685836)
2. O. Warburg On the origin of cancer cells Science 123 1956 309 314
3. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: The metabolic requirements of cell proliferation Science 324 2009 1029 1033
4. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: Rationale and promise Cancer Cell 4 2003 257 262 (Pubitemid 37329790)
5. B. Lanpher, N. Brunetti-Pierri, and B. Lee Inborn errors of metabolism: The flux from Mendelian to complex diseases Nat. Rev. Genet. 7 2006 449 460 (Pubitemid 43780488)
6. D. Marsden, C. Larson, and H.L. Levy Newborn screening for metabolic disorders J. Pediatr. 148 2006 577 584
7. T.H. Zytkovicz, E.F. Fitzgerald, D. Marsden, C.A. Larson, V.E. Shih, D.M. Johnson, A.W. Strauss, A.M. Comeau, R.B. Eaton, and G.F. Grady Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A two-year summary from the New England Newborn Screening Program Clin. Chem. 47 2001 1945 1955 (Pubitemid 33010710)
8. D.H. Chace, T.A. Kalas, and E.W. Naylor The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism Annu. Rev. Genomics Hum. Genet. 3 2002 17 45 (Pubitemid 35217429)
9. I.V. Schwartz, C.F. Souza, and R. Giugliani Treatment of inborn errors of metabolism J. Pediatr. (Rio J.) 84 4, Suppl 2008 S8 S19
10. S.E. Waisbren, S. Albers, S. Amato, M. Ampola, T.G. Brewster, L. Demmer, R.B. Eaton, R. Greenstein, M. Korson, and C. Larson Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress JAMA 290 2003 2564 2572 (Pubitemid 37443286)
11. I.K. Onal, N. Turhan, E. Oztas, M. Arhan, Z. Akcoren, P. Oguz, M. Akdogan, E.D. Onal, S. Kacar, M. Kurt, and N. Sasmaz Hepatocellular carcinoma in an adult patient with type IV glycogen storage disease Acta Gastroenterol. Belg. 72 2009 377 378
12. R.A. de Moor, J.J. Schweizer, B. van Hoek, M. Wasser, R. Vink, and P.D. Maaswinkel-Mooy Hepatocellular carcinoma in glycogen storage disease type IV Arch. Dis. Child. 82 2000 479 480 (Pubitemid 30367057)
13. N. Burnichon, J.J. Brire, R. Libé, L. Vescovo, J. Rivire, F. Tissier, E. Jouanno, X. Jeunemaitre, P. Bénit, and A. Tzagoloff SDHA is a tumor suppressor gene causing paraganglioma Hum. Mol. Genet. 19 2010 3011 3020
14. Brusilow, S.W., and Horwich, A.L. (2009). Amino Acids: Urea Cycle Enzymes. In Metabolic and Molecular Bases of Inherited Disease, Eighth Edition, Chapter 8, C. Scriver, et al, eds. (New York: McGraw-Hill). www.ommbid.com
15. K. Broedbaek, H.E. Poulsen, A. Weimann, G.D. Kom, E. Schwedhelm, P. Nielsen, and R.H. Böger Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis Free Radic. Biol. Med. 47 2009 1230 1233
16. W.G. Kaelin Jr. SDH5 mutations and familial paraganglioma: Somewhere Warburg is smiling Cancer Cell 16 2009 180 182
17. J.B. Litten, and G.E. Tomlinson Liver tumors in children Oncologist 13 2008 812 820
18. J. Soeda, M. Yazaki, T. Nakata, S. Miwa, S. Ikeda, W. Hosoda, M. Iijima, K. Kobayashi, T. Saheki, M. Kojiro, and S. Miyagawa Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: A case report J. Clin. Gastroenterol. 42 2008 855 860
19. S. Marhenke, J. Lamlé, L.E. Buitrago-Molina, J.M. Cañón, R. Geffers, M. Finegold, M. Sporn, M. Yamamoto, M.P. Manns, M. Grompe, and A. Vogel Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development Hepatology 48 2008 487 496
20. S.A. Harrison, and B.R. Bacon Relation of hemochromatosis with hepatocellular carcinoma: Epidemiology, natural history, pathophysiology, screening, treatment, and prevention Med. Clin. North Am. 89 2005 391 409 (Pubitemid 40126823)
21. F. Lithner, and L. Wetterberg Hepatocellular carcinoma in patients with acute intermittent porphyria Acta Med. Scand. 215 1984 271 274 (Pubitemid 14128237)
22. N. Savas, O. Canan, F. Ozcay, B. Bilezikci, H. Karakayali, U. Yilmaz, and M. Haberal Hepatocellular carcinoma in Wilson's disease: A rare association in childhood Pediatr. Transplant. 10 2006 639 643
23. R. Xu, P. Mistry, G. McKenna, S. Emre, T. Schiano, M. Bu-Ghanim, G. Levi, and M.I. Fiel Hepatocellular carcinoma in type 1 Gaucher disease: A case report with review of the literature Semin. Liver Dis. 25 2005 226 229 (Pubitemid 40781074)
24. L.M. Franco, V. Krishnamurthy, D. Bali, D.A. Weinstein, P. Arn, B. Clary, A. Boney, J. Sullivan, D.P. Frush, Y.T. Chen, and P.S. Kishnani Hepatocellular carcinoma in glycogen storage disease type Ia: A case series J. Inherit. Metab. Dis. 28 2005 153 162 (Pubitemid 40723883)
25. E. Demo, D. Frush, M. Gottfried, J. Koepke, A. Boney, D. Bali, Y.T. Chen, and P.S. Kishnani Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J. Hepatol. 46 2007 492 498 (Pubitemid 46185700)
26. K.F. Kok, P.J. Wahab, R.H. Houwen, J.P. Drenth, R.A. de Man, B. van Hoek, J.W. Meijer, F.L. Willekens, and R.A. de Vries Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: A review Neth. J. Med. 65 2007 160 166 (Pubitemid 47161617)
27. P.H. Yin, H.C. Lee, G.Y. Chau, Y.T. Wu, S.H. Li, W.Y. Lui, Y.H. Wei, T.Y. Liu, and C.W. Chi Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma Br. J. Cancer 90 2004 2390 2396 (Pubitemid 38961905)
28. T.A. Dragani Risk of HCC: Genetic heterogeneity and complex genetics J. Hepatol. 52 2010 252 257
29. M. Di Rocco, M.G. Calevo, M. Taro', D. Melis, A.E. Allegri, and G. Parenti Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease Mol. Genet. Metab. 93 2008 398 402
30. M. St-Louis, and R.M. Tanguay Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: Overview Hum. Mutat. 9 1997 291 299 (Pubitemid 27157647)
31. S.T. Pitkänen, M.K. Salo, and M. Heikinheimo Hereditary tyrosinaemia type I: From basics to progress in treatment Ann. Med. 32 2000 530 538
32. M. Grompe The pathophysiology and treatment of hereditary tyrosinemia type 1 Semin. Liver Dis. 21 2001 563 571 (Pubitemid 33131048)
33. S. Manabe, S. Sassa, and A. Kappas Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts J. Exp. Med. 162 1985 1060 1074 (Pubitemid 16248208)
34. R. Jorquera, and R.M. Tanguay The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion Biochem. Biophys. Res. Commun. 232 1997 42 48 (Pubitemid 27211916)
35. A.G. Weinberg, C.E. Mize, and H.G. Worthen The occurrence of hepatoma in the chronic form of hereditary tyrosinemia J. Pediatr. 88 1976 434 438
36. F.J. van Spronsen, Y. Thomasse, G.P. Smit, J.V. Leonard, P.T. Clayton, V. Fidler, R. Berger, and H.S. Heymans Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment Hepatology 20 1994 1187 1191 (Pubitemid 24323564)
37. E. Holme, and S. Lindstedt Nontransplant treatment of tyrosinemia Clin. Liver Dis. 4 2000 805 814
38. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, F. Dormishian, R. Domingo Jr., M.C. Ellis, and A. Fullan A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat. Genet. 13 1996 399 408 (Pubitemid 26256612)
39. M. Franchini, and D. Veneri Recent advances in hereditary hemochromatosis Ann. Hematol. 84 2005 347 352 (Pubitemid 40823346)
40. K.V. Kowdley, T. Hassanein, S. Kaur, F.J. Farrell, D.H. Van Thiel, E.B. Keeffe, M.F. Sorrell, B.R. Bacon, F.L. Weber Jr., and A.S. Tavill Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis Liver Transpl. Surg. 1 1995 237 241
41. R.L. Nelson, F.G. Davis, V. Persky, and E. Becker Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis Cancer 76 1995 875 879
42. P.O. Gannon, S. Medelci, C. Le Page, M. Beaulieu, D.M. Provencher, A.M. Mes-Masson, and M.M. Santos Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis Int. J. Cancer. 2010 10.1002/ijc.25577 in press. Published online July 28, 2010
43. N.J. Osborne, L.C. Gurrin, K.J. Allen, C.C. Constantine, M.B. Delatycki, C.E. McLaren, D.M. Gertig, G.J. Anderson, M.C. Southey, and J.K. Olynyk HFE C282Y homozygotes are at increased risk of breast and colorectal cancer Hepatology 51 2010 1311 1318
44. M.D. Kew Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: Occurrence in noncirrhotic patients Hepatology 11 1990 1086 1087 (Pubitemid 20221051)
45. S. Toyokuni Role of iron in carcinogenesis: Cancer as a ferrotoxic disease Cancer Sci. 100 2009 9 16
46. L.R. Zacharski, B.K. Chow, P.S. Howes, G. Shamayeva, J.A. Baron, R.L. Dalman, D.J. Malenka, C.K. Ozaki, and P.W. Lavori Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial J. Natl. Cancer Inst. 100 2008 996 1002 (Pubitemid 352019800)
47. L. Hardell, N.O. Bengtsson, U. Jonsson, S. Eriksson, and L.G. Larsson Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation Br. J. Cancer 50 1984 389 397
48. M.S. Linet, G. Gridley, O. Nyrén, L. Mellemkjaer, J.H. Olsen, S. Keehn, H.O. Adami, and J.F. Fraumeni Jr. Primary liver cancer, other malignancies, and mortality risks following porphyria: A cohort study in Denmark and Sweden Am. J. Epidemiol. 149 1999 1010 1015 (Pubitemid 29246865)
49. H. Puy, U. Gross, J.C. Deybach, A.M. Robréau, M. Frank, Y. Nordmann, and M. Doss Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria Hum. Genet. 103 1998 570 575 (Pubitemid 28548479)
50. A.L. Herrick, and K.E. McColl Acute intermittent porphyria Best Pract. Res. Clin. Gastroenterol. 19 2005 235 249
51. C. Andersson, L. Bjersing, and F. Lithner The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria J. Intern. Med. 240 1996 195 201 (Pubitemid 26356041)
52. J.P. Kushner, A.J. Barbuto, and G.R. Lee An inherited enzymatic defect in porphyria cutanea tarda: Decreased uroporphyrinogen decarboxylase activity J. Clin. Invest. 58 1976 1089 1097
53. J. Frank, and P. Poblete-Gutiérrez Porphyria cutanea tarda - when skin meets liver Best Pract. Res. Clin. Gastroenterol. 24 2010 735 745
54. Z.J. Bulaj, J.D. Phillips, R.S. Ajioka, M.R. Franklin, L.M. Griffen, D.J. Guinee, C.Q. Edwards, and J.P. Kushner Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda Blood 95 2000 1565 1571 (Pubitemid 30120814)
55. T. Douki, J. Onuki, M.H. Medeiros, E.J. Bechara, J. Cadet, and P. Di Mascio DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid Chem. Res. Toxicol. 11 1998 150 157 (Pubitemid 28128447)
56. C. Palmieri, D.M. Vigushin, and T.J. Peters Managing malignant disease in patients with porphyria QJM 97 2004 115 126 (Pubitemid 38351260)
57. P. de Bie, P. Muller, C. Wijmenga, and L.W. Klomp Molecular pathogenesis of Wilson and Menkes disease: Correlation of mutations with molecular defects and disease phenotypes J. Med. Genet. 44 2007 673 688 (Pubitemid 350161581)
58. D. Huster Wilson disease Best Pract. Res. Clin. Gastroenterol. 24 2010 531 539
59. J.M. Walshe, E. Waldenström, V. Sams, H. Nordlinder, and K. Westermark Abdominal malignancies in patients with Wilson's disease QJM 96 2003 657 662 (Pubitemid 37063275)
60. M.L. Wilkinson, B. Portmann, and R. Williams Wilson's disease and hepatocellular carcinoma: Possible protective role of copper Gut 24 1983 767 771 (Pubitemid 13030245)
61. J. Wu, J.R. Forbes, H.S. Chen, and D.W. Cox The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene Nat. Genet. 7 1994 541 545 (Pubitemid 24308344)
62. R. Masuda, M.C. Yoshida, M. Sasaki, K. Dempo, and M. Mori High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis Jpn. J. Cancer Res. 79 1988 828 835
63. Y. Zhang, M. Li, Q. Yao, and C. Chen Roles and mechanisms of copper transporting ATPases in cancer pathogenesis Med. Sci. Monit. 15 2009 RA1 RA5
64. M. Jmoudiak, and A.H. Futerman Gaucher disease: Pathological mechanisms and modern management Br. J. Haematol. 129 2005 178 188 (Pubitemid 40562438)
65. H.C. Bertram, M. Eldibany, J. Padgett, and L.H. Dragon Splenic lymphoma arising in a patient with Gaucher disease. A case report and review of the literature Arch. Pathol. Lab. Med. 127 2003 e242 e245
66. P. Böhm, W. Kunz, H.P. Horny, and H. Einsele Adult Gaucher disease in association with primary malignant bone tumors Cancer 91 2001 457 462 (Pubitemid 32105689)
67. A. Balreira, L. Lacerda, C.S. Miranda, and F.A. Arosa Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: Monocytes from Gaucher disease patients as a model Br. J. Haematol. 129 2005 667 676 (Pubitemid 40825829)
68. D.A. Hughes Enzyme, substrate, and myeloma in Gaucher disease Am. J. Hematol. 84 2009 199 201
69. J.E. Compston Bone marrow and bone: A functional unit J. Endocrinol. 173 2002 387 394 (Pubitemid 34704710)
70. M. de Fost, S. Vom Dahl, G.J. Weverling, N. Brill, S. Brett, D. Häussinger, and C.E. Hollak Increased incidence of cancer in adult Gaucher disease in Western Europe Blood Cells Mol. Dis. 36 2006 53 58 (Pubitemid 43061488)
71. T.H. Taddei, K.A. Kacena, M. Yang, R. Yang, A. Malhotra, M. Boxer, K.A. Aleck, G. Rennert, G.M. Pastores, and P.K. Mistry The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients Am. J. Hematol. 84 2009 208 214
72. S. Chappell, L. Daly, K. Morgan, T. Guetta Baranes, J. Roca, R. Rabinovich, A. Millar, S.C. Donnelly, V. Keatings, and W. MacNee Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease Hum. Mutat. 27 2006 103 109 (Pubitemid 43042972)
73. R.G. Crystal Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy J. Clin. Invest. 85 1990 1343 1352 (Pubitemid 20176425)
74. R.T. Abboud, G.T. Ford, K.R. Chapman Standards Committee of the Canadian Thoracic Society Alpha1-antitrypsin deficiency: A position statement of the Canadian Thoracic Society Can. Respir. J. 8 2001 81 88 (Pubitemid 32496355)
75. T. Köhnlein, and T. Welte Alpha-1 antitrypsin deficiency: Pathogenesis, clinical presentation, diagnosis, and treatment Am. J. Med. 121 2008 3 9
76. K.A. McGlynn, E.A. Rosvold, E.D. Lustbader, Y. Hu, M.L. Clapper, T. Zhou, C.P. Wild, X.L. Xia, A. Baffoe-Bonnie, and D. Ofori-Adjei Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 Proc. Natl. Acad. Sci. USA 92 1995 2384 2387
77. D.H. Perlmutter Liver injury in alpha1-antitrypsin deficiency: An aggregated protein induces mitochondrial injury J. Clin. Invest. 110 2002 1579 1583 (Pubitemid 35424232)
78. S. Manekeller, T. Sauerbruch, H.P. Fischer, P. Propping, and A. Hirner Heterozygous alpha-1-antitrypsin deficiency (PiMZ): Risk factor in the development of primary liver carcinoma in non-cirrhotic liver? Z. Gastroenterol. 48 2010 1211 1214
79. J.H. Teckman, J.K. An, K. Blomenkamp, B. Schmidt, and D. Perlmutter Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency Am. J. Physiol. Gastrointest. Liver Physiol. 286 2004 G851 G862
80. D. Cassiman, K. Claes, E. Lerut, R. Oyen, S. Joniau, B. Van Damme, and J. Jaeken Bilateral renal cell carcinoma development in long-term Fabry disease J. Inherit. Metab. Dis. 30 2007 830 831 (Pubitemid 47559894)
81. J. Blanco, J. Herrero, L.F. Arias, N. Garcia-Miralles, C. Gamez, and A. Barrientos Renal variant of Anderson-Fabry disease and bilateral renal cell carcinoma Pathol. Res. Pract. 200 2005 857 860 (Pubitemid 40220972)
82. C.S. Nance, C.J. Klein, M. Banikazemi, S.H. Dikman, R.G. Phelps, J.C. McArthur, M. Rodriguez, and R.J. Desnick Later-onset Fabry disease: An adult variant presenting with the cramp-fasciculation syndrome Arch. Neurol. 63 2006 453 457
83. A. Mehta, M. Beck, F. Eyskens, C. Feliciani, I. Kantola, U. Ramaswami, A. Rolfs, A. Rivera, S. Waldek, and D.P. Germain Fabry disease: A review of current management strategies QJM 103 2010 641 659
84. R.Y. Wang, A. Lelis, J. Mirocha, and W.R. Wilcox Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life Genet. Med. 9 2007 34 45 (Pubitemid 46115959)
85. C.D. Young, and S.M. Anderson Sugar and fat - that's where it's at: Metabolic changes in tumors Breast Cancer Res. 10 2008 202
86. J.F. Barger, and D.R. Plas Balancing biosynthesis and bioenergetics: Metabolic programs in oncogenesis Endocr. Relat. Cancer 17 2010 R287 R304
87. L. Robb, I. Lyons, R. Li, L. Hartley, F. Köntgen, R.P. Harvey, D. Metcalf, and C.G. Begley Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene Proc. Natl. Acad. Sci. USA 92 1995 7075 7079
88. K.J. Lei, L.L. Shelly, C.J. Pan, J.B. Sidbury, and J.Y. Chou Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a Science 262 1993 580 583 (Pubitemid 23350674)
89. J.P. Rake, G. Visser, P. Labrune, J.V. Leonard, K. Ullrich, and G.P. Smit Glycogen storage disease type I: Diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I) Eur. J. Pediatr. 161 Suppl 1 2002 S20 S34
90. J.Y. Chou, and B.C. Mansfield Mutations in the glucose-6-phosphatase- alpha (G6PC) gene that cause type Ia glycogen storage disease Hum. Mutat. 29 2008 921 930 (Pubitemid 351951286)
91. J. Shen, Y. Bao, H.M. Liu, P. Lee, J.V. Leonard, and Y.T. Chen Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle J. Clin. Invest. 98 1996 352 357 (Pubitemid 26255733)
92. Y. Endo, A. Horinishi, M. Vorgerd, Y. Aoyama, T. Ebara, T. Murase, M. Odawara, T. Podskarbi, Y.S. Shin, and M. Okubo Molecular analysis of the AGL gene: Heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey J. Hum. Genet. 51 2006 958 963 (Pubitemid 44800740)
93. M. Siciliano, E. De Candia, S. Ballarin, F.M. Vecchio, S. Servidei, R. Annese, R. Landolfi, and L. Rossi Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease J. Clin. Gastroenterol. 31 2000 80 82 (Pubitemid 30430255)
94. C. Bruno, O.P. van Diggelen, D. Cassandrini, M. Gimpelev, B. Giuffr, M.A. Donati, P. Introvini, A. Alegria, S. Assereto, and L. Morandi Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV) Neurology 63 2004 1053 1058 (Pubitemid 39287914)
95. H. Ozen Glycogen storage diseases: New perspectives World J. Gastroenterol. 13 2007 2541 2553 (Pubitemid 46938823)
96. N.S. Alshak, J. Cocjin, L. Podesta, R. van de Velde, L. Makowka, P. Rosenthal, and S.A. Geller Hepatocellular adenoma in glycogen storage disease type IV Arch. Pathol. Lab. Med. 118 1994 88 91 (Pubitemid 24020193)
97. P. Labrune Glycogen storage disease type I: Indications for liver and/or kidney transplantation Eur. J. Pediatr. 161 Suppl 1 2002 S53 S55
98. P.J. Lee Glycogen storage disease type I: Pathophysiology of liver adenomas Eur. J. Pediatr. 161 Suppl 1 2002 S46 S49
99. R.H. Bandsma, G.P. Smit, and F. Kuipers Disturbed lipid metabolism in glycogen storage disease type 1 Eur. J. Pediatr. 161 Suppl 1 2002 S65 S69
100. P.S. Kishnani, T.P. Chuang, D. Bali, D. Koeberl, S. Austin, D.A. Weinstein, E. Murphy, Y.T. Chen, K. Boyette, and C.H. Liu Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease Hum. Mol. Genet. 18 2009 4781 4790
101. T. Bourgeron, P. Rustin, D. Chretien, M. Birch-Machin, M. Bourgeois, E. Viegas-Péquignot, A. Munnich, and A. Rötig Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency Nat. Genet. 11 1995 144 149
102. A.S. Tischler Pheochromocytoma and extra-adrenal paraganglioma: Updates Arch. Pathol. Lab. Med. 132 2008 1272 1284
103. A.P. Gimenez-Roqueplo New advances in the genetics of pheochromocytoma and paraganglioma syndromes Ann. N. Y. Acad. Sci. 1073 2006 112 121
104. I.P. Tomlinson, N.A. Alam, A.J. Rowan, E. Barclay, E.E. Jaeger, D. Kelsell, I. Leigh, P. Gorman, H. Lamlum, S. Rahman Multiple Leiomyoma Consortium Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat. Genet. 30 2002 406 410
105. H.P. Hsiao, L.S. Kirschner, I. Bourdeau, M.F. Keil, S.A. Boikos, S. Verma, A.J. Robinson-White, M. Nesterova, A. Lacroix, and C.A. Stratakis Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors J. Clin. Endocrinol. Metab. 94 2009 2930 2937
106. J.P. Bayley, V. Launonen, and I.P. Tomlinson The FH mutation database: An online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency BMC Med. Genet. 9 2008 20
107. C.A. Stratakis, and J.A. Carney The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): Molecular genetics and clinical implications J. Intern. Med. 266 2009 43 52
108. E.R. Maher, and C. Eng The pressure rises: Update on the genetics of phaeochromocytoma Hum. Mol. Genet. 11 2002 2347 2354 (Pubitemid 35174697)
109. C.J. Ricketts, J.R. Forman, E. Rattenberry, N. Bradshaw, F. Lalloo, L. Izatt, T.R. Cole, R. Armstrong, V.K. Kumar, and P.J. Morrison Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD Hum. Mutat. 31 2010 41 51
110. R.D. Guzy, B. Sharma, E. Bell, N.S. Chandel, and P.T. Schumacker Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis Mol. Cell. Biol. 28 2008 718 731
111. K.F. Andersen, R. Altaf, A. Krarup-Hansen, B. Kromann-Andersen, T. Horn, N.J. Christensen, and H.W. Hendel Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach Cancer Treat. Rev. 37 2011 111 119
112. B.E. Baysal, J.E. Willett-Brozick, E.C. Lawrence, C.M. Drovdlic, S.A. Savul, D.R. McLeod, H.A. Yee, D.E. Brackmann, W.H. Slattery 3rd, and E.N. Myers Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas J. Med. Genet. 39 2002 178 183 (Pubitemid 34252553)
113. P.J. Pollard, J.J. Brire, N.A. Alam, J. Barwell, E. Barclay, N.C. Wortham, T. Hunt, M. Mitchell, S. Olpin, and S.J. Moat Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations Hum. Mol. Genet. 14 2005 2231 2239 (Pubitemid 41418022)
114. W.M. Linehan, R. Srinivasan, and L.S. Schmidt The genetic basis of kidney cancer: A metabolic disease Nat Rev Urol 7 2010 277 285
115. B.G. Slane, N. Aykin-Burns, B.J. Smith, A.L. Kalen, P.C. Goswami, F.E. Domann, and D.R. Spitz Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability Cancer Res. 66 2006 7615 7620 (Pubitemid 44289218)
116. M. Brandon, P. Baldi, and D.C. Wallace Mitochondrial mutations in cancer Oncogene 25 2006 4647 4662 (Pubitemid 44187615)
117. S. Lee, E. Nakamura, H. Yang, W. Wei, M.S. Linggi, M.P. Sajan, R.V. Farese, R.S. Freeman, B.D. Carter, W.G. Kaelin Jr., and S. Schlisio Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer Cancer Cell 8 2005 155 167 (Pubitemid 41132744)
118. M. Topu, F. Jobard, S. Halliez, T. Coskun, C. Yalinkayal, F.O. Gerceker, R.J. Wanders, J.F. Prud'homme, M. Lathrop, M. Ozguc, and J. Fischer L-2-Hydroxyglutaric aciduria: Identification of a mutant gene C14orf160, localized on chromosome 14q22.1 Hum. Mol. Genet. 13 2004 2803 2811 (Pubitemid 39562544)
119. E. Van Schaftingen, R. Rzem, and M. Veiga-da-Cunha L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair J. Inherit. Metab. Dis. 32 2009 135 142
120. P.A. Oziik, N. Akalan, S. Palaolu, and M. Topu Medulloblastoma in a child with the metabolic disease L-2-hydroxyglutaric aciduria Pediatr. Neurosurg. 37 2002 22 26 (Pubitemid 34920739)
121. I. Moroni, M. Bugiani, L. D'Incerti, C. Maccagnano, M. Rimoldi, L. Bissola, B. Pollo, G. Finocchiaro, and G. Uziel L-2-hydroxyglutaric aciduria and brain malignant tumors: A predisposing condition? Neurology 62 2004 1882 1884 (Pubitemid 38661759)
122. R.E. Rogers, R.J. Deberardinis, L.J. Klesse, R.L. Boriack, L.R. Margraf, and D. Rakheja Wilms tumor in a child with L-2-hydroxyglutaric aciduria Pediatr. Dev. Pathol. 13 2010 408 411
123. P.S. Ward, J. Patel, D.R. Wise, O. Abdel-Wahab, B.D. Bennett, H.A. Coller, J.R. Cross, V.R. Fantin, C.V. Hedvat, and A.E. Perl The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate Cancer Cell 17 2010 225 234
124. K. Garber Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia J. Natl. Cancer Inst. 102 2010 926 928
125. N.K. Kloosterhof, L.B. Bralten, H.J. Dubbink, P.J. French, and M.J. van den Bent Isocitrate dehydrogenase-1 mutations: A fundamentally new understanding of diffuse glioma? Lancet Oncol. 12 2011 83 91
126. S. Gross, R.A. Cairns, M.D. Minden, E.M. Driggers, M.A. Bittinger, H.G. Jang, M. Sasaki, S. Jin, D.P. Schenkein, and S.M. Su Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations J. Exp. Med. 207 2010 339 344
127. L. Dang, S. Jin, and S.M. Su IDH mutations in glioma and acute myeloid leukemia Trends Mol. Med. 16 2010 387 397
128. J. Smeitink Metabolism, gliomas, and IDH1 N. Engl. J. Med. 362 2010 1144 1145
129. L. Dang, D.W. White, S. Gross, B.D. Bennett, M.A. Bittinger, E.M. Driggers, V.R. Fantin, H.G. Jang, S. Jin, and M.C. Keenan Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 2009 739 744
130. Z.J. Reitman, and H. Yan Isocitrate dehydrogenase 1 and 2 mutations in cancer: Alterations at a crossroads of cellular metabolism J. Natl. Cancer Inst. 102 2010 932 941
131. S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, and Y. Peng Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 324 2009 261 265
132. Y. Fu, R. Huang, J. Du, R. Yang, N. An, and A. Liang Glioma-derived mutations in IDH: From mechanism to potential therapy Biochem. Biophys. Res. Commun. 397 2010 127 130
133. K. Kobayashi, D.S. Sinasac, M. Iijima, A.P. Boright, L. Begum, J.R. Lee, T. Yasuda, S. Ikeda, R. Hirano, and H. Terazono The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein Nat. Genet. 22 1999 159 163 (Pubitemid 29264809)
134. T. Saheki, and K. Kobayashi Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD) J. Hum. Genet. 47 2002 333 341 (Pubitemid 34733510)
135. D. Dimmock, B. Maranda, C. Dionisi-Vici, J. Wang, S. Kleppe, G. Fiermonte, R. Bai, B. Hainline, A. Hamosh, and W.E. O'Brien Citrin deficiency, a perplexing global disorder Mol. Genet. Metab. 96 2009 44 49
136. N. Hagiwara, Y. Sekijima, Y. Takei, S. Ikeda, S. Kawasaki, K. Kobayashi, and T. Saheki Hepatocellular carcinoma in a case of adult-onset type II citrullinemia Intern. Med. 42 2003 978 982 (Pubitemid 37407643)
137. A. Kimura, M. Kage, I. Nagata, S. Mushiake, T. Ohura, Y. Tazawa, S. Maisawa, T. Tomomasa, D. Abukawa, and Y. Okano Histological findings in the livers of patients with neonatal intrahepatic cholestasis caused by citrin deficiency Hepatol. Res. 40 2010 295 303
138. H. Nagasaka, Y. Okano, H. Tsukahara, Y. Shigematsu, T. Momoi, J. Yorifuji, T. Miida, T. Ohura, K. Kobayashi, and T. Saheki Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period Mol. Genet. Metab. 97 2009 21 26
139. T. Ito, K. Shiraki, K. Sekoguchi, T. Yamanaka, K. Sugimoto, K. Takase, Y. Tameda, and T. Nakano Hepatocellular carcinoma associated with adult-type citrullinemia Dig. Dis. Sci. 45 2000 2203 2206 (Pubitemid 32060393)
140. G. Solaini, G. Sgarbi, and A. Baracca Oxidative phosphorylation in cancer cells Biochim. Biophys. Acta 2010 10.1016/j.bbabio.2010.09.003 in press. Published online September 26, 2010
141. B.A. Kunz, and S.E. Kohalmi Modulation of mutagenesis by deoxyribonucleotide levels Annu. Rev. Genet. 25 1991 339 359 (Pubitemid 21903725)
142. P.Y. Ke, Y.Y. Kuo, C.M. Hu, and Z.F. Chang Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability Genes Dev. 19 2005 1920 1933
143. S.J. Ralph, S. Rodríguez-Enríquez, J. Neuzil, E. Saavedra, and R. Moreno-Sánchez The causes of cancer revisited: "Mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy Mol. Aspects Med. 31 2010 145 170
144. J.E. Klaunig, L.M. Kamendulis, and B.A. Hocevar Oxidative stress and oxidative damage in carcinogenesis Toxicol. Pathol. 38 2010 96 109
145. D.P. Dimmock, J.K. Dunn, A. Feigenbaum, A. Rupar, R. Horvath, P. Freisinger, B. Mousson de Camaret, L.J. Wong, and F. Scaglia Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency Liver Transpl. 14 2008 1480 1485
146. A.W. El-Hattab, F.Y. Li, E. Schmitt, S. Zhang, W.J. Craigen, and L.J. Wong MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: New patients and novel mutations Mol. Genet. Metab. 99 2010 300 308
147. C.L. Karadimas, T.H. Vu, S.A. Holve, P. Chronopoulou, C. Quinzii, S.D. Johnsen, J. Kurth, E. Eggers, L. Palenzuela, and K. Tanji Navajo neurohepatopathy is caused by a mutation in the MPV17 gene Am. J. Hum. Genet. 79 2006 544 548 (Pubitemid 44384263)
148. A. Spinazzola, C. Viscomi, E. Fernandez-Vizarra, F. Carrara, P. D'Adamo, S. Calvo, R.M. Marsano, C. Donnini, H. Weiher, and P. Strisciuglio MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion Nat. Genet. 38 2006 570 575
149. I. Scheers, V. Bachy, X. Stephenne, and E.M. Sokal Risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders J. Pediatr. 146 2005 414 417 (Pubitemid 40341755)
150. B.A. Kunz Mutagenesis and deoxyribonucleotide pool imbalance Mutat. Res. 200 1988 133 147
151. M. Kulawiec, A. Safina, M.M. Desouki, I. Still, S. Matsui, A. Bakin, and K.K. Singh Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion Cancer Biol. Ther. 7 2008 1732 1743
152. A. Naito, C.C. Cook, T. Mizumachi, M. Wang, C.H. Xie, T.T. Evans, T. Kelly, and M. Higuchi Progressive tumor features accompany epithelial- mesenchymal transition induced in mitochondrial DNA-depleted cells Cancer Sci. 99 2008 1584 1588
153. H.O. Akman, B. Dorado, L.C. López, A. García-Cazorla, M.R. Vil, L.M. Tanabe, W.T. Dauer, E. Bonilla, K. Tanji, and M. Hirano Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance Hum. Mol. Genet. 17 2008 2433 2440
154. L.C. López, H.O. Akman, A. García-Cazorla, B. Dorado, R. Martí, I. Nishino, S. Tadesse, G. Pizzorno, D. Shungu, and E. Bonilla Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice Hum. Mol. Genet. 18 2009 714 722
155. C. Dallabona, R.M. Marsano, P. Arzuffi, D. Ghezzi, P. Mancini, M. Zeviani, I. Ferrero, and C. Donnini Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator Hum. Mol. Genet. 19 2010 1098 1107
156. N. Fukuhara, S. Tokiguchi, K. Shirakawa, and T. Tsubaki Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): Disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature J. Neurol. Sci. 47 1980 117 133 (Pubitemid 10082950)
157. E. Holme, N.G. Larsson, A. Oldfors, M. Tulinius, P. Sahlin, and G. Stenman Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A - >G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome Am. J. Hum. Genet. 52 1993 551 556 (Pubitemid 23311325)
158. M. Yoneda, Y. Tanno, S. Horai, T. Ozawa, T. Miyatake, and S. Tsuji A common mitochondrial DNA mutation in the t-RNA(Lys) of patients with myoclonus epilepsy associated with ragged-red fibers Biochem. Int. 21 1990 789 796 (Pubitemid 20281253)
159. K. Schoffer, and I. Grant Multiple lipomas, alcoholism, and neuropathy: Madelung's disease or MERRF? Muscle Nerve 33 2006 142 146 (Pubitemid 43062998)
160. H.A. Teive, R.P. Munhoz, J.A. Muzzio, R.H. Scola, C.K. Kay, S. Raskin, L.C. Werneck, and H. Bruhn Cerebellar ataxia, myoclonus, cervical lipomas, and MERRF syndrome. Case report Mov. Disord. 23 2008 1191 1192
161. N. Mizushima, B. Levine, A.M. Cuervo, and D.J. Klionsky Autophagy fights disease through cellular self-digestion Nature 451 2008 1069 1075 (Pubitemid 351317450)
162. L. Scott, J. Lamb, S. Smith, and D.N. Wheatley Single amino acid (arginine) deprivation: Rapid and selective death of cultured transformed and malignant cells Br. J. Cancer 83 2000 800 810
163. B.J. Dillon, V.G. Prieto, S.A. Curley, C.M. Ensor, F.W. Holtsberg, J.S. Bomalaski, and M.A. Clark Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: A method for identifying cancers sensitive to arginine deprivation Cancer 100 2004 826 833 (Pubitemid 38176863)
164. S.M. Lagarde, P.E. Ver Loren van Themaat, P.D. Moerland, L.A. Gilhuijs-Pederson, F.J. Ten Kate, P.H. Reitsma, A.H. van Kampen, A.H. Zwinderman, F. Baas, and J.J. van Lanschot Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus Ann. Surg. Oncol. 15 2008 3459 3470
165. E. Kobayashi, M. Masuda, R. Nakayama, H. Ichikawa, R. Satow, M. Shitashige, K. Honda, U. Yamaguchi, A. Shoji, and N. Tochigi Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma Mol. Cancer Ther. 9 2010 535 544
166. A.A. Tytell, and R.E. Neuman Growth response of stable and primary cell cultures to L-ornithine, L-citrulline, and L-arginine Exp. Cell Res. 20 1960 84 91
167. G.E. Kenny, and M.E. Pollock Mammalian cell cultures contaminated with pleuropneumonia-like organisms. I. Effect of pleuropneumonia-like organisms on growth of established cell strains J. Infect. Dis. 112 1963 7 16
168. P.M. Kraemer Mycoplasma (Pplo) from Covertly Contaminated Tissue Cultures: Differences in Arginine Degradation between Strains Proc. Soc. Exp. Biol. Med. 117 1964 910 918
169. R.T. Schimke, C.M. Berlin, E.W. Sweeney, and W.R. Carroll The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07 J. Biol. Chem. 241 1966 2228 2236
170. R.H. Kim, J.M. Coates, T.L. Bowles, G.P. McNerney, J. Sutcliffe, J.U. Jung, R. Gandour-Edwards, F.Y. Chuang, R.J. Bold, and H.J. Kung Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis Cancer Res. 69 2009 700 708
171. L.J. Shen, K. Beloussow, and W.C. Shen Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase Cancer Lett. 231 2006 30 35 (Pubitemid 41779450)
172. F. Izzo, P. Marra, G. Beneduce, G. Castello, P. Vallone, V. De Rosa, F. Cremona, C.M. Ensor, F.W. Holtsberg, and J.S. Bomalaski Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies J. Clin. Oncol. 22 2004 1815 1822 (Pubitemid 41095171)
173. P.A. Ascierto, S. Scala, G. Castello, A. Daponte, E. Simeone, A. Ottaiano, G. Beneduce, V. De Rosa, F. Izzo, and M.T. Melucci Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies J. Clin. Oncol. 23 2005 7660 7668 (Pubitemid 46291831)
174. T. Severi, S. Vander Borght, L. Libbrecht, L. VanAelst, F. Nevens, T. Roskams, D. Cassiman, J. Fevery, C. Verslype, and J.F. van Pelt HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development Chem. Biol. Interact. 168 2007 128 134 (Pubitemid 46898369)
175. H. Pelicano, D. Carney, and P. Huang ROS stress in cancer cells and therapeutic implications Drug Resist. Updat. 7 2004 97 110 (Pubitemid 38736063)
176. V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria as targets for chemotherapy Apoptosis 14 2009 624 640
177. J.G. Pastorino, and J.B. Hoek Regulation of hexokinase binding to VDAC J. Bioenerg. Biomembr. 40 2008 171 182
178. K.K. Arora, and P.L. Pedersen Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP J. Biol. Chem. 263 1988 17422 17428 (Pubitemid 19029327)
179. D.C. Wallace A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine Annu. Rev. Genet. 39 2005 359 407 (Pubitemid 43011120)
180. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase-2 bound to mitochondria: Cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy Semin. Cancer Biol. 19 2009 17 24
181. G. Di Chiro, R.L. DeLaPaz, R.A. Brooks, L. Sokoloff, P.L. Kornblith, B.H. Smith, N.J. Patronas, C.V. Kufta, R.M. Kessler, and G.S. Johnston Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1982 1323 1329 (Pubitemid 13218489)
182. K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R.B. Robey, and N. Hay Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase Genes Dev. 15 2001 1406 1418 (Pubitemid 32524647)
183. X. Cao, M. Bloomston, T. Zhang, W.L. Frankel, G. Jia, B. Wang, N.C. Hall, R.M. Koch, H. Cheng, M.V. Knopp, and D. Sun Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor Clin. Cancer Res. 14 2008 1831 1839 (Pubitemid 351469470)
184. X. Zhang, E. Varin, M. Briand, S. Allouche, N. Heutte, L. Schwartz, L. Poulain, and P. Icard Novel therapy for malignant pleural mesothelioma based on anti-energetic effect: An experimental study using 3-Bromopyruvate on nude mice Anticancer Res. 29 2009 1443 1448
185. J.A. Petros, A.K. Baumann, E. Ruiz-Pesini, M.B. Amin, C.Q. Sun, J. Hall, S. Lim, M.M. Issa, W.D. Flanders, and S.H. Hosseini mtDNA mutations increase tumorigenicity in prostate cancer Proc. Natl. Acad. Sci. USA 102 2005 719 724 (Pubitemid 40282732)
186. Y. Shidara, K. Yamagata, T. Kanamori, K. Nakano, J.Q. Kwong, G. Manfredi, H. Oda, and S. Ohta Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis Cancer Res. 65 2005 1655 1663 (Pubitemid 40478589)
187. M.L. Verschoor, L.A. Wilson, and G. Singh Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer Can. J. Physiol. Pharmacol. 88 2010 204 219
188. H. Suzuki, T. Kumagai, A. Goto, and T. Sugiura Increase in intracellular hydrogen peroxide and upregulation of a nuclear respiratory gene evoked by impairment of mitochondrial electron transfer in human cells Biochem. Biophys. Res. Commun. 249 1998 542 545 (Pubitemid 28431790)
189. R.H. Burdon Superoxide and hydrogen peroxide in relation to mammalian cell proliferation Free Radic. Biol. Med. 18 1995 775 794
190. T.J. Preston, W.J. Muller, and G. Singh Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response J. Biol. Chem. 276 2001 9558 9564
191. K.Z. Guyton, Y. Liu, M. Gorospe, Q. Xu, and N.J. Holbrook Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury J. Biol. Chem. 271 1996 4138 4142
192. K.M. Connor, S. Subbaram, K.J. Regan, K.K. Nelson, J.E. Mazurkiewicz, P.J. Bartholomew, A.E. Aplin, Y.T. Tai, J. Aguirre-Ghiso, S.C. Flores, and J.A. Melendez Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation J. Biol. Chem. 280 2005 16916 16924 (Pubitemid 41389151)
193. S. Shimizu, M. Kageyama, M. Yasuda, D. Sasaki, S. Naito, T. Yamamoto, and Y. Kiuchi Stimulation of in vitro angiogenesis by nitric oxide through the induction of transcription factor ETS-1 Int. J. Biochem. Cell Biol. 36 2004 114 122 (Pubitemid 37338477)
194. X.Z. Sun, C. Vinci, L. Makmura, S. Han, D. Tran, J. Nguyen, M. Hamann, S. Grazziani, S. Sheppard, and M. Gutova Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization Antioxid. Redox Signal. 5 2003 655 665 (Pubitemid 37315155)
195. T. Oltersdorf, S.W. Elmore, A.R. Shoemaker, R.C. Armstrong, D.J. Augeri, B.A. Belli, M. Bruncko, T.L. Deckwerth, J. Dinges, and P.J. Hajduk An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435 2005 677 681 (Pubitemid 40825512)
196. J.L. Wang, D. Liu, Z.J. Zhang, S. Shan, X. Han, S.M. Srinivasula, C.M. Croce, E.S. Alnemri, and Z. Huang Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells Proc. Natl. Acad. Sci. USA 97 2000 7124 7129 (Pubitemid 30431428)
197. J.S. Penta, F.M. Johnson, J.T. Wachsman, and W.C. Copeland Mitochondrial DNA in human malignancy Mutat. Res. 488 2001 119 133 (Pubitemid 32436427)
198. A. Argon, A. Aydiner, F. Tas, P. Saip, and E. Topuz Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome Gynecol. Oncol. 85 2002 362 364 (Pubitemid 34522999)
199. E. Wasserman, A. Myara, F. Lokiec, F. Goldwasser, F. Trivin, M. Mahjoubi, J.L. Misset, and E. Cvitkovic Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports Ann. Oncol. 8 1997 1049 1051 (Pubitemid 27475739)
200. J.P. Leone, and A.Z. Dudek Enzyme replacement therapy for Gaucher's disease in patient treated for non-small cell lung cancer Anticancer Res. 28 6B 2008 3937 3939
201. B. Vogelstein, and K.W. Kinzler The multistep nature of cancer Trends Genet. 9 1993 138 141 (Pubitemid 23098782)